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Edited by Richard MaraisAbstract Several diﬀerent types of interactions between sphin-
gosine-1-phosphate (S1P) receptors and platelet-derived growth
factor receptor (PDGFR) have been revealed recently. In this
work, we used HEK293 cells to further investigate the potential
crosstalk. Interestingly, we observed that S1P speciﬁcally in-
duced a PDGFR-dependent cell detachment in HEK293 cells,
which could be inhibited by AG1296, a speciﬁc inhibitor for
PDGFR. EGFR on the other hand, did not have any eﬀect on cell
detachment. The detachment was extracellular matrix (ECM)
protein speciﬁc, suggesting the involvement of speciﬁc integrin
molecules. When b1 integrin was engaged into an active state,
S1P-induced cell detachment was blocked, suggesting that S1P
induced an inside-out inhibitory eﬀect on b1 integrin. Gi protein
and ERK activation were required for the cell detachment in-
duced by S1P, suggesting an endogenous receptor for S1P is
likely to be involved.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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G protein coupled receptors (GPCRs), receptor tyrosine ki-
nases (RTKs), and integrins are three major types of plasma
membrane receptors that are involved in numerous cellular
processes, including cell growth, survival, diﬀerentiation,
adhesion, migration, and invasion. These receptors mediate
distinct as well as overlapping intracellular signaling events,
and interactions among these receptors play very important
roles in many cellular eﬀects [1–7]. Studies from numerous re-Abbreviations: ECM, extracellular matrix; EGF, epidermal growth
factor; GPCR, G protein coupled receptor; IGF, insulin-like
growth factor; LPA, lysophosphatidic acid; PDGFR, platelet-derived
growth factor receptor; RTK, receptor tyrosine kinase; Sph, sphingo-
sine-1-phosphate (S1P); SPC, sphingosylphosphorylcholine
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doi:10.1016/j.febslet.2005.06.006ports suggest that crosstalk exists between many types of
receptors, as well as at many levels of signaling pathways
[1–7].
S1P is a bioactive lipid molecule, involved in many impor-
tant cellular processes [8]. Several types of interactions be-
tween S1P (it activates its receptors which belong to the
GPCR family) and PDGFR (belongs to the RTK family)
have been previously reported. The ‘‘sequential model’’ de-
picts the production of S1P induced by PDGF as the medi-
ator of the interaction, and PDGF is dependent on S1P1 to
induce cell motility [9]. In contrast, the ‘‘integrative model’’
suggests that a physical interaction between S1P1 and
PDGFR, but not S1P production, plays an important role
and the signaling eﬃciencies (measured by ERK activation)
of both S1P and PDGF are increased (bi-directional)
[10,11]. We have recently shown that another S1P receptor
subtype (S1P3, rather than S1P1) is involved in the interac-
tion between S1P and PDGF signaling and a ‘‘reciprocal’’
requirement exists, i.e., S1P-induced Akt phosphorylation
via S1P3 requires PDGFR [12]. These data are not mutually
exclusive, but suggest that interactions between S1P and
PDGF are signaling pathway-, S1P receptor subtype-,
and cell type-speciﬁc. These interactions between S1P and
PDGFR may play important physiological and pathological
regulatory roles.
Integrin engagement during cell adhesion regulates gene
expression, cell growth, diﬀerentiation, and survival. These
events are controlled by biochemical signals generated by li-
gand-occupied and clustered integrins (out-side-in signals)
[13]. In addition, integrins are also regulated by inside-out
signals. Intracellular signals generated by a variety of agonists
can modulate cell adhesion by regulating integrin–matrix
interactions [13,14]. Integrins provide an intersection where
mechanical forces, cytoskeletal organization, biochemical sig-
nals and adhesion meet, which is critical in cell shape mor-
phology, polarity, and motility [13]. While the activating
signals have been more extensively studied, the inhibitory in-
side-out regulation has only been minimally explored. In one
case, Wang et al. [15] show that death-associated protein
kinase (DAP-kinase) induces apoptosis via suppression of
integrin-mediated cell adhesion and signal transduction.
DAP-kinase downregulates integrin activity through an in-
side-out inhibitory mechanism, which is completely abolished
by enforced activation of integrin-mediated signaling path-
ways from either integrin itself or its downstream eﬀector,
focal adhesion kinase [15].blished by Elsevier B.V. All rights reserved.
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nous PDGFR to further explore the potential crosstalk be-
tween S1P and PDGFR. We conﬁrmed that ectopic
expression of PDGFR in HEK293 cells enhanced S1P-stimu-
lated ERK activation [16]. We demonstrated a novel interac-
tion among three membrane receptors: a receptor for S1P,
PDGFR and b1 integrin. Interestingly, an inside-out inhibitory
signal resulted from interaction of S1P and PDGFR led to cell
detachment, but not cell apoptosis or cell death. This eﬀect was
highly ligand-, receptor-, and ECM-speciﬁc.2. Materials and methods
2.1. Reagents
Sphingosine-1-phosphate (S1P), lysophosphatidic acid (LPA),
sphingosylphosphorylcholine (SPC), sphingosine (Sph) were from
Aventi Polar Lipids (Birmingham, AL) or Toronto Research Chemi-
cals (Toronto, Canada). Platelet-derived growth factor-BB (PDGF-
BB) was from Chemicon International (Temecula, CA). Epidermal
growth factor (EGF) and insulin were from Sigma (St. Louis, MO).
The b1 activating integrin antibody (MAB1951Z-20), b1 blocking
(MAB1959) and non-functional antibody (MAB1952) were obtained
from Chemicon International. Pertussis toxin (PTX) was purchased
from Invitrogen (Rockville, MD). AG1296, AG1478 and AG1024
were obtained from Biomol (Plymouth Meeting, PA). Human Laminin
10/11 (puriﬁed protein, Cat #AG56P) and other ECM proteins were
from Chemicon International. Poly-lysine and fatty-acid free BSA
were purchased from Sigma (St. Louis, MO). pET15b Talin-H 38-
429 from mouse was a kind gift of Dr. Jun Qin at the Cleveland Clinic
Foundation. pcDNA3.1-dn-PDGFRb (dominant negative PDGFRb)
was a kind gift from Dr. A Kazlauskas from Schepens Eye Research
Institute, Harvard Medical School.
2.2. Cell culture and transfection
HEK293 cells were cultured in DMEM or RPMI1640 with 10%
FCS. All cells were cultured in serum free media for 18–24 h before
lipid treatment. The pcDNA3.1(+) vector or human PDGFRb cDNA
in pcDNA3.1(+) were transfected into HEK293 cells using Lipofect-
AMINE reagent (Invitrogen, CA) according to manufacturers instruc-
tions. Cells were selected in DMEM with 10% FCS and 600 lg/mL of
G418 (Invitrogen CA). 5 lg of pcDNA3.1(+)-Talin, 8 lg of
pcDNA3.1(+)-EGFR and 10 lg pcDNA3.1-dnPDGFRb (dominant
negative PDGFRb) were transiently transfected using Lipofect-
AMINE (Invitrogen, CA). All transiently transfected cells were used
within 48–60 h post-transfection.Fig. 1. S1P induced ERK, but not Akt activation. (A) Parental HEK293 cells
ml) and insulin (100 nM) for 10 and 60 min, respectively. Western blot analyse
ERK) and total ERK. Data shown are the representative results from three i
used were for p-AKT (p-S473-Akt) and total Akt.2.3. Detachment assays
The 96 or 6 well plates were coated with vitronectin, laminin, colla-
gen I, collagen IV, ﬁbronectin or Poly-Lysine (10 lg/mL) for 1 and
1/2 h. The wells were washed with PBS and then blocked by 1%
BSA (fatty acid free) in PBS for 1 and 1/2 h at 37 C. Wells were
washed and starved cells (1 · 105) were seeded in each well in 100 ll
(96 well plate) and 2 ml (6 well plate) and allowed to attach for 3–
4 h. After treatment, the non-detached and detached cells were counted
in the presence of trypan-blue.3. Results
3.1. S1P induced ERK, but not Akt activation in HEK293 cells
To address the role of PDGFR in S1P-signaling, we investi-
gated the S1P signaling in HEK293 cells, which do not express
endogenous PDGFR, but express at least two S1P receptors,
S1P2 and S1P3 [9,10]. In parental HEK293 cell, S1P (0.1–
10 lM), but not insulin (10 lM), epidermal growth factor
(EGF; 10–20 ng/mL), or PDGF (5–20 ng/mL) induced a tran-
sient ERK activation (Fig. 1A), suggesting that S1P receptor(s)
in HEK293 is functional. However, S1P was unable to induce
Akt activation in these cells (Fig. 1B). Among the factors
tested, S1P (0.1–10 lM), PDGF (10 ng/mL), EGF (10–20 ng/
mL), and insulin (1–10 lM), only insulin was able to induce
phosphorylation at S473 of Akt (Fig. 1B). Since we have
shown that PDGFR is required for S1P-induced Akt activa-
tion in ﬁbroblasts and certain cancer cells [12], we wanted to
determine whether ectopic expression of PDGFR in HEK293
cells was suﬃcient for Akt activation by S1P. We established
PDGFR transfected HEK293 cells and expression of the
PDGFRb was conﬁrmed by Western blot analyses using anti-
body against PDGFRb (Fig. 2A). In HEK293 cells either tran-
siently or stably transfected by PDGFRb, S1P (1 lM)-induced
ERK activation was enhanced in PDGFR-expressing cells,
when compared to vector-transfected or parental cells (Fig.
2B). PD98095, an inhibitor of MEK, the upstream activator
of ERK, blocked the ERK activation by S1P and PDGF-BB
(Fig. 2C). These results are consistent with previous reports
[10,17,18], except we did not overexpress S1P1 in HEK293
cells, suggesting that activation of ERK by S1P can be medi-
ated by a crosstalk between an endogenous S1P receptor(s)were stimulated with S1P (1 lM), PDGF-BB (10 ng/mL), EGF (10 ng/
s were performed using the antibodies against phosphorylated ERK (p-
ndependent experiments. (B) Same as in (A), except that the antibodies
Fig. 3. PDGFR expressing HEK293 cells detached from tissue culture
dishes upon S1P and PDGF stimulation. Parental, vector transfected
(pcDNA3.1) and PDGFRb expressing HEK293 cells (clone #2) were
cultured in tissue culture dishes and treated with S1P (1 lM), PDGF-
BB (10 ng/mL), sphingosine (Sph; 1 lM), SPC (1 lM), LPA (10 lM)
or EGF (10 ng/mL). Signiﬁcant detachment was not observed in vector
transfected or parental cells. Cell detachment was measured as
described in Section 2. Results are summarized from three independent
experiments. \\\P < 0.001 (the Student t-test).
Fig. 2. PDGFR expression in HEK293 enhanced S1P-induced ERK activation. (A) Parental HEK293 cells were stably transfected with PDGFR.
Western blot analysis was performed using an antibody against PDGFR. ‘‘control (+)’’ indicates a positive control (U251 cell lysate); ‘‘control ()’’
indicates a negative control (pcDNA 3.1-HEK293 cell lysate); ‘‘#2’’, ‘‘#4’’ and ‘‘#6’’ indicate clones selected for their expression of PDGFRb
(PDGFRb-HEK293 cell lysates). Unless transient transfection was performed, Clone #2 was used in all the experiments described in this paper.
Some of the experiments were repeated using clone #6. (B) Parental HEK293 and PDGFR stably transfected cells were stimulated with S1P (1 lM)
and PDGF-BB (10 ng/mL) for 10 min. Western blot analyses were performed using the antibodies against ERK (p-ERK) and total ERK. More than
three similar independent experiments have been conducted. (C) PDGFR stably transfected cells were pretreated with PD98095 as described in
Section 2, prior to treatment with S1P (1 lM) or PDGF (10 ng/mL).
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even when PDGFR was expressed, suggesting that expression
of PDGFR is not suﬃcient for S1P to activate Akt in HEK293
cells.3.2. S1P, but not other compounds, induced a PDGFR-
dependent cell detachment in HEK293 cells
We observed an unexpected phenomenon in PDGFRb-
expressing HEK293 cells. When S1P (1 lM) was added to
dishes of the PDGFRb-expressing HEK293 cells (PDGFR-
HEK293) (after 16–24 h starvation from serum), within
10 min, 80–95% cells were detached from the plate. This S1P
induced cell detachment was not observed in either parental
or vector-transfected cells, indicating this is a PDGFR-depen-
dent eﬀect (Figs. 3; 4A, a,h, and B, a,b; and Table 1). The
ligand of PDGFR, PDGF-BB (10–20 ng/mL) also induced
cells detachment, but to a lesser extent (60–70%) (Fig. 3 and
Table 1), suggesting that an interaction between a S1P receptor
and PDGFR enhances this eﬀect. To determine whether this
was a S1P- and PDGF-speciﬁc eﬀect, we treated PDGFR-
HEK293 cells with EGF (10 ng/mL), LPA (1, 10 lM), sphin-
gosine (Sph; 1 lM), and SPC (1 lM). Only S1P (1 lM) and
PDGF-BB (10 ng/mL) signiﬁcantly detached the majority of
cells (Fig. 3).
Fig. 4. S1P diﬀerentially detached cells from diﬀerent matrixes. (A) 6-well plate was coated with diﬀerent ECM as described in Section 2. Starved
PDGFRb expressing cells (clone #2) were allowed to attach for 3–4 h prior to their treatment with S1P (1 lM). The ﬁrst row shows cells attached to
diﬀerent matrixes with no S1P treatment and the second row shows cells after S1P treatment. Tissue culture dishes (a,h); laminin (b,i); vitronectin
(c,j); ﬁbronectin (d,k); poly-lysine (e,l); collagen I (f); collagen IV (g). (B) Starved pcDNA3.1 vector transfected cells were allowed to attach to the
tissue culture dishes for 4 h before being treated with S1P. (a) pcDNA3.1 cells attached to a tissue culture plate, (b) same as in (a), but treated with
S1P.
Table 1
The speciﬁcity of cell detachment
Cells ECM Lipid Growth factor
Lipid Detachment (%) Time Growth factor Detachment (%) Time
pcDNA3.1 TCP S1P <10 P 1.5 h PDGF, EGF <10 P 1.5 h
PDGFRb TCP S1P 80–95 610 min PDGF 60–70 10 min
LPA, Sph, SPC <10 P 1.5 h EGF <10 P 1.5 h
Laminin 10/11 S1P 85–95 610 min PDGF 65–75 10 min
Vitronectin S1P 85–95 10 min PDGF 30–40 10 min
Fibronectin S1P 25–35 P 1.5 h
Collagen I S1P 30–45 P 1.5 h
Collagen IV S1P <10 P 1.5 h
Poly-Lysine S1P 0 P 1.5 h PDGF 0 P 1.5 h
96 or 6-well plates were coated with diﬀerent ECM proteins as described in Section 2. HEK293 vector transfected (pcDNA3.1) or PDGFRb
transfected cells (clone #2) were allowed to attach either to the tissue culture plate (TCP) or diﬀerent proteins for 3–4 h before the detachment
experiment was performed. The detachment process was monitored for up to 24 h post treatment.
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or anoikis [19]. However, we found that the cells detached by
S1P were not dead (even after 16 h, >90% ﬂoating cells were
alive judged by trypan-blue exclusion).
3.3. S1P induced diﬀerential cell detachment from diﬀerent
ECMs
Cell attachment to tissue culture surface may involve acti-
vation of adhesion molecules (such as integrins) and/or
charge-based interactions. To determine which of these inter-
actions play an important role in this attachment-
detachment process, we seeded cells on diﬀerent extracellular
matrixes (ECM) proteins (10 lg/mL of each: laminin 10/11,
vitronectin, ﬁbronectin, collagen I, and Collagen IV). BSA
(0.1%) was used as a negative control for cell attachment
and Poly-lysine was used as a positive control for cell attach-
ment via charged interactions, but a negative control for
adhesion molecule- (such as integrins) mediated cell adhe-
sion. After 3–4 h incubation, cells were attached to diﬀerentECMs and poly-lysine (Fig. 4A, b–g), but not to BSA (the
negative control; data not shown). When these cells were
treated with S1P (1 lM), diﬀerential detachments were ob-
served. As shown in Table 1 and Fig. 4A, 85–95% cells
quickly (less than 10 min) detached from laminin 10/11. Cell
detachment from vitronectin (85–95% of cells) took approx-
imately 10 min while detachment from other ECM proteins
was slower (more than 1 h) and to a lesser extent: ﬁbronectin
(25–35% of cells), collagen I (30–45% of cells), and collagen
IV (<10% of cells). In contrast, cells adhered to poly-lysine
ﬁrmly (although they did not spread) even 24–72 h after
S1P treatment (Table 1 and Fig. 4A, e–l). These results indi-
cate that the S1P-induced cell detachment involves speciﬁc
adhesion molecules and does not aﬀect charge-based interac-
tion-mediated cell attachment (as in the case of Poly-lysine).
While PDGF-BB also had detachment eﬀect (although
weaker than S1P), LPA, SPC and Sph had no eﬀect on cell
detachment conﬁrming detachment to be a highly speciﬁc
eﬀect for S1P (Table 1).
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were required for S1P-induced cell detachment from laminin
and vitronectin
To determine the functional involvement of PDGFR, we
treated cells with AG1296, a speciﬁc PDGFR tyrosine kinase
inhibitor, followed by S1P (1 lM). The cell detachment from
laminin (Fig. 5A) and vitronectin (Fig. 5B) was signiﬁcantly
blocked, indicating the kinase activity of PDGFR was required
for this process. In contrast, AG1024 (an inhibitor for IGF
receptor) or AG1478 (an inhibitor for EGFR) did not inhibit
S1P-induced cell detachment (Fig. 5A and B). Furthermore,
in contrast to the wild type PDGFR-transfected cells, neither
S1P, nor PDGF-BB (or EGF) induced cell detachment in
HEK293 cells transfected with a dominant negative form of
PDGFR or the wild-type EGFR, conﬁrming the importance
and speciﬁcity of PDGFRb in this action (Fig. 5C).
S1P1–3 couple to Gi proteins [20,21]. Pretreatment of
PDGFRb expressing cells with Pertussis toxin (PTX; a speciﬁc
inhibitor for Gi protein) or PD98095 led to a prevention of the
S1P induced detachment, suggesting that Gi protein and MEK
are required for this eﬀect (Fig. 5A and B).Fig. 5. S1P-induced cell detachment required PDGFR, Gi protein and ERK
attach to laminin and pretreated with AG1296 (10 lM), AG1024 (10 lM), A
(1 lM) treatment. (B) Same as in (A), but cells were attached to vitron
\\\P < 0.001 (the Student t-test). (C) HEK293 cells were transiently transf
PDGFRb) as described in Section 2. Cell detachment level was measured af
mL). Signiﬁcant detachment was observed only in cells stably expressing PDG
stimulated with S1P (5 lM) and PDGF-BB (10–30 ng/mL) for 5 min. For AG
performed using the antibodies against phosphorylated (pTyr751) PDGFRbIn an attempt to determine the mechanism of the crosstalk
between S1P and PDGFR, we tested the ability of S1P to in-
duce PDGFR tyrosine phosphorylation (Fig. 5D). While
PDGF-BB (10–30 ng/mL) induced tyrosine phosphorylation
at Y751, S1P (5 lM) did not induce tyrosine phosphorylation
of PDGFR at this site (Fig. 5D). This result is consistent with a
previous report showing that S1P is unable to induce tyrosine
phosphorylation of PDGFR in HEK293 cells [16], suggesting
that direct transactivation of PDGFR by S1P may not be in-
volved in S1P-PDGFR crosstalk.
3.5. Integrins are involved in S1P-induced cell detachment
S1P induced a rapid and almost complete cell detachment
from laminin 10/11 and vitronectin. b1 integrins are the major
receptors for laminin 10/11 [22]. Five b1 integrins can bind to
laminin 10/11: a1b1, a2b1, a3 b1, a6b1, and a7b1. Although
avb3 integrin is a major receptor for vitronectin in many cell
types, the avb1 integrin has been identiﬁed as the predominant
receptor for vitronectin in HEK293 cells, which do not express
detectable b2, b3, or aIIb [23]. HEK293 cells have been shown
to express at least six b1 integrins: avb1, a1b1, a2b1, a3b1,activity. (A) Cells expressing PDGFRb (clone #2) were allowed to
G1478 (200 nM), PTX (100 ng/mL), or PD98095 (10 lM) prior to S1P
ectin. Results are summarized from three independent experiments.
ected with EGFR and a dominant negative form of PDGFRb (dn-
ter treatment with S1P (1 lM), PDGF-BB (10 ng/mL) or EGF (10 ng/
FRb (clone #2). (D) PDGFRb stably transfected cells (clone #2) were
1296 (10 M), 45 min pretreatment was used. Western blot analyses were
and total PDGFR.
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inhibitory signaling to b1 integrin(s), we ﬁrst pretreated cells
with a blocking antibody against b1 integrin and found that
cells were not able to attach to laminin or vitronectin. We then
used non-functional and activating antibodies against b1 inte-
grin to treat cells. Treatment with the activating antibody
would engage the integrin into an activated state and thus ren-
der the inhibitory signal ineﬀective. Indeed, we found that pre-
treatment with this antibody, but not a non-functional b1
integrin antibody, completely prevented cells detachment from
laminin (Fig. 6A) or vitronectin (Fig. 6B) induced by S1P or
PDGF-BB (Fig. 6A). To conﬁrm the inside-out inhibitory ef-
fect, we employed two additional methods to activate b1 inte-Fig. 6. An inside-out inhibitory eﬀect on b1 integrin is involved in
S1P-induced cell detachment. (A) Prior to attachment, starved
PDGFRb-expressing cells (clone #2) were pretreated with diﬀerent
antibodies(1 lg/500 000 cells/0.5 mL) or Mn2+ (1 mM) for 30 min.
After cell attachment, they were left untreated or treated with S1P
(1 lM) or PDGF-BB (10 ng/mL). Talin transfection and cell detach-
ment analyses are described in Section 2. (B) Same as in (A), but cells
were attached to vitronectin. Results are summarized from three
independent experiments. \\\P < 0.001 (the Student t-test).
Fig. 7. Schematic summary of the S1P-induced inside-out inhibition of
b1 integrin, which results in cell detachment. An endogenous S1P
receptor interacts with the PDGF receptor via coupling to a Gi
protein. This interaction enhances ERK activation, which, in turn
leads to the integrin inactivation, followed by cell detachment from the
extracellular matrix (ECM).grin. Integrins can be expressed in at least three functional
states (i.e. latent, active, and ligand-occupied). Mn2+ induces
localized conformational changes that mimic a ligand-
occupied receptor [15,25]. Talin, a cytoskeletal actin-binding
protein, activates the cytoplasmic portion of b1 integrin by
binding to it [26,27]. Cells treated with Mn2+ or transfected
with an active form of talin were resistant to S1P-induced cell
detachment (Fig. 6A and B). Fig. 7 summarizes the data and
interactions that involve multiple receptors. Our data are also
consistent with the observations that b1 blocking antibody
inhibits cell attachment to laminin, vitronectin, and ﬁbronectin
in HEK293 cells observed by others [23].4. Discussion
While the signal transduction studies on individual signaling
pathways or multiple signaling pathways mediated by a single
receptor have generated enormous knowledge, and have had
impressive impact in the past decades, integration among mul-
tiple individual signaling pathways, as well as crosstalk among
receptors and multiple stimuli have begun to attract more
attention. All cells express multiple receptors, and they are
constitutively exposed to multiple stimuli in vivo. The interac-
tions between receptors and signaling pathways are likely to be
tissue-, cell type-, stimulus-, and receptor subtype-speciﬁc. In
this work, we have revealed a novel multiple receptor eﬀect,
which is highly speciﬁc in terms of stimulus, receptors, and
ECM proteins.
Both S1P and PDGF regulate many important cellular ef-
fects. In particular, they both play important roles in angio-
genesis and cell migration [8,9,28–34]. The physiological
signiﬁcance of the observed eﬀect remains to be further inves-
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mary site prior to migration, which is a critical step in tumor
cell metastasis. In addition, cell de-adhesion is potentially
important for the ability of a cell to participate in morphogen-
esis and to respond to injurious stimuli [35]. Intriguingly, in
contrast to many other cellular systems, where inhibiting inte-
grins induces anoikis [19], the b1 integrin inhibitory signal
shown here does not induce cell death and/or apoptosis. This
is consistent with our results showing that ERK1/2, a major
proliferative signaling molecule is activated and required for
this inside-out inhibitory eﬀect. Together, our data suggest
that the S1P-induced cell detachment in PDGFR-expressing
HEK293 cells represents an active cellular process, which
may play a role in enhancing cell motility and/or other cellular
functions.
Three types of mechanisms regarding crosstalks at the recep-
tor level have been well described: (1) a sequential model; (2)
transactivation; and (3) an integration models. The nature of
a ‘‘sequential model’’ in crosstalk is that the key function of
one player in the cross talk (e.g. PDGF or S1P) is to stimulate
the production/secretion of the other player it interacts with.
Our data do not support or exclude this model of action.
Although we did not directly measure whether S1P could stim-
ulate production/secretion of PDGF, it is unlikely to be the
case. First, if S1Ps function was mediated by production
and/or secretion of PDGF, PDGF would be more eﬀective
than S1P in cell detachment. However, we have found that
PDGF-BB was less eﬀective than S1P in inducing cell detach-
ment. Secondly, the cell detachment eﬀect induced by S1P was
very rapid when cells were cultured on laminin or vitronectin,
cell detachment was observed immediately after S1P treatment
and the process was completed (with >85% cell detached) in
10 min. Production/secretion of the second factor usually re-
quires more time.
Although we tested the ability of S1P in tyrosine
phosphorylation only at one site (Y751) of PDGFR, our re-
sults are consistent with the previous report that S1P does
not phosphorylate PDGFRb in HEK293 cells [17],
suggesting that transactivation of PDGFR by S1P is not in-
volved.
The cell detachment observed in this work is in line with
the integrative model. Similar to what was observed by Ald-
erton et al. [10], we have conﬁrmed that S1P induces an en-
hanced ERK activation in a PDGFR-dependent manner.
One diﬀerence between the work by Alderton et al. [10]
and our current work is that we did not overexpress any
exogenous S1P receptor in HEK293 cells. However, at least
two S1P receptors (S1P2 and S1P3) are expressed in
HEK293 cells [9] and our results (ERK activation) suggest
that at least one endogenous S1P receptor is functional. Fur-
thermore, the sensitivity of the S1P-induced cell detachment
to PTX suggests that the S1P-induced eﬀect requires a
Gi-coupled receptor. S1P1–3, can all couple to Gi [20]. Alder-
ton et al. [10] have shown that a Gia is required for ERK
activation induced by PDGF inHEK293 cells. Interestingly,
although overexpression of S1P1 enhances the activities,
PDGF has been shown to activate ERK in a PTX-sensitive
manner and induces tyrosine phosphorylation of Gia when
PDGFR alone is transfected, suggesting that PDGF and its
receptor also interact with an endogenous S1P receptor [10].
Thus, although the particular endogenous S1P receptor in-
volved in the crosstalk leading to cell detachment remainsto be determined, our results are consistent with the integra-
tive model.
S1P is unable to induce Akt phosphorylation even when
PDGFR is expressed in HEK293 cells. Except insulin, we
have found that other factors, such as LPA and EGF,
which are able to activate Akt in numerous cell types [36],
were also unable to induce Akt phosphorylation in
HEK293 cells (Fig. 1B and data not shown). We have pro-
posed that insulin-induced Akt activation has a distinct
mechanism from those induced by lipid factors, endothelin,
EGF and PDGF [36]. These results suggest that HEK293
may lack a critical component that is necessary for Akt acti-
vation by lipid factors and growth factors. Alternatively,
HEK293 cells may have a general inhibitory factor for
Akt activation by these factors. These issues need to be fur-
ther investigated.
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